New pacing technique could boost heart function in mild failure

NCT ID NCT06126081

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares a special pacemaker procedure called left bundle branch pacing (LBBP) plus standard heart failure drugs against drugs alone in 36 people with mild heart failure. The goal is to see if early pacing improves the heart's pumping ability more than medication. Participants will be followed for 6 months to measure changes in heart function.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Left bundle branch pacing (a pacemaker procedure) plus guideline-directed medical therapy (standard heart failure drugs)
What this could lead to
If successful, this could offer a more effective way to improve heart pumping function and reduce symptoms in certain heart failure patients.
What could go wrong
This is a small, early-stage trial with only 36 participants, so results may not apply widely. The procedure carries risks like infection or lead displacement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100037, China

  • The first affiliated hospital of Nanjing medical university

    Nanjing, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.